XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.81

+1.1%

Dec 16 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (14667)	9/16/2000 9:52:20 PM
From: Robert K.	Read Replies (1) of 17367

Saving a kid in africa is just as important as saving a kid in USA (or anywhere else), the thing is though, that its the money they make from the USA trials that pays for drug access in the poorer nations. No USA appoval, little access. ..... Hmmmm, waiting for your anti-clot comeback....... While you are thinking, what does protein c do (besides replacing protein c defeciancies). And isnt reperfusion a problem with DIC (and sepsis). So lets see, we have antibacterial effects, anti-endotoxin effects, anti-clot and clot disolution effects. But yet bpi does not work. IMO BPI has a great chance to work, lets give it the chance it needs to be proven and lets do it NOW before more kids die.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next